nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketotifen—PDE4D—breast cancer	0.553	1	CbGaD
Ketotifen—PGD—Methotrexate—breast cancer	0.0626	1	CbGbCtD
Ketotifen—PDE8A—mammary gland—breast cancer	0.00382	0.0488	CbGeAlD
Ketotifen—PDE8A—nipple—breast cancer	0.00316	0.0404	CbGeAlD
Ketotifen—PDE4A—mammary gland—breast cancer	0.00306	0.0392	CbGeAlD
Ketotifen—PDE7A—female reproductive system—breast cancer	0.00252	0.0323	CbGeAlD
Ketotifen—PDE7B—adipose tissue—breast cancer	0.0024	0.0307	CbGeAlD
Ketotifen—PGD—mammary gland—breast cancer	0.00232	0.0297	CbGeAlD
Ketotifen—PDE7B—adrenal gland—breast cancer	0.00215	0.0275	CbGeAlD
Ketotifen—PDE7A—endocrine gland—breast cancer	0.00214	0.0273	CbGeAlD
Ketotifen—PDE8B—uterus—breast cancer	0.00195	0.025	CbGeAlD
Ketotifen—PGD—nipple—breast cancer	0.00192	0.0245	CbGeAlD
Ketotifen—PDE8B—adipose tissue—breast cancer	0.00191	0.0244	CbGeAlD
Ketotifen—PDE8A—endometrium—breast cancer	0.00191	0.0244	CbGeAlD
Ketotifen—PDE8A—uterus—breast cancer	0.00176	0.0225	CbGeAlD
Ketotifen—PDE8B—female reproductive system—breast cancer	0.00176	0.0225	CbGeAlD
Ketotifen—PDE8A—pituitary gland—breast cancer	0.00173	0.0221	CbGeAlD
Ketotifen—PDE8A—adipose tissue—breast cancer	0.00172	0.022	CbGeAlD
Ketotifen—PDE8B—adrenal gland—breast cancer	0.00171	0.0219	CbGeAlD
Ketotifen—PDE4D—adipose tissue—breast cancer	0.00156	0.0199	CbGeAlD
Ketotifen—PDE8A—adrenal gland—breast cancer	0.00154	0.0197	CbGeAlD
Ketotifen—PDE4B—nipple—breast cancer	0.00151	0.0193	CbGeAlD
Ketotifen—PDE8B—endocrine gland—breast cancer	0.00149	0.019	CbGeAlD
Ketotifen—PDE8A—female gonad—breast cancer	0.00144	0.0184	CbGeAlD
Ketotifen—PDE4D—adrenal gland—breast cancer	0.0014	0.0179	CbGeAlD
Ketotifen—PDE4A—adipose tissue—breast cancer	0.00138	0.0176	CbGeAlD
Ketotifen—PDE4D—female gonad—breast cancer	0.0013	0.0167	CbGeAlD
Ketotifen—PDE7B—lymph node—breast cancer	0.00129	0.0165	CbGeAlD
Ketotifen—PDE4A—adrenal gland—breast cancer	0.00124	0.0158	CbGeAlD
Ketotifen—PGD—skin of body—breast cancer	0.00123	0.0157	CbGeAlD
Ketotifen—PGD—endometrium—breast cancer	0.00116	0.0148	CbGeAlD
Ketotifen—PDE4A—female gonad—breast cancer	0.00115	0.0147	CbGeAlD
Ketotifen—PGD—uterus—breast cancer	0.00107	0.0137	CbGeAlD
Ketotifen—PGD—pituitary gland—breast cancer	0.00105	0.0134	CbGeAlD
Ketotifen—PGD—adipose tissue—breast cancer	0.00104	0.0134	CbGeAlD
Ketotifen—PDE8B—lymph node—breast cancer	0.00103	0.0131	CbGeAlD
Ketotifen—PGD—female reproductive system—breast cancer	0.00096	0.0123	CbGeAlD
Ketotifen—PGD—adrenal gland—breast cancer	0.000937	0.012	CbGeAlD
Ketotifen—PDE8A—lymph node—breast cancer	0.000924	0.0118	CbGeAlD
Ketotifen—PDE4B—endometrium—breast cancer	0.000912	0.0117	CbGeAlD
Ketotifen—PGD—bone marrow—breast cancer	0.000906	0.0116	CbGeAlD
Ketotifen—PGD—female gonad—breast cancer	0.000874	0.0112	CbGeAlD
Ketotifen—HRH1—nipple—breast cancer	0.000868	0.0111	CbGeAlD
Ketotifen—PDE4D—lymph node—breast cancer	0.000837	0.0107	CbGeAlD
Ketotifen—PDE4B—pituitary gland—breast cancer	0.000825	0.0105	CbGeAlD
Ketotifen—PDE4B—adipose tissue—breast cancer	0.000822	0.0105	CbGeAlD
Ketotifen—PGD—endocrine gland—breast cancer	0.000812	0.0104	CbGeAlD
Ketotifen—PDE4B—female reproductive system—breast cancer	0.000755	0.00966	CbGeAlD
Ketotifen—PDE4A—lymph node—breast cancer	0.000741	0.00948	CbGeAlD
Ketotifen—PDE4B—adrenal gland—breast cancer	0.000737	0.00942	CbGeAlD
Ketotifen—PDE4B—bone marrow—breast cancer	0.000713	0.00912	CbGeAlD
Ketotifen—PDE4B—female gonad—breast cancer	0.000687	0.00879	CbGeAlD
Ketotifen—PDE4B—endocrine gland—breast cancer	0.000639	0.00817	CbGeAlD
Ketotifen—HRH1—epithelium—breast cancer	0.000585	0.00748	CbGeAlD
Ketotifen—PGD—lymph node—breast cancer	0.000562	0.00718	CbGeAlD
Ketotifen—HRH1—endometrium—breast cancer	0.000524	0.0067	CbGeAlD
Ketotifen—Loratadine—CYP2D6—breast cancer	0.000481	0.288	CrCbGaD
Ketotifen—HRH1—adipose tissue—breast cancer	0.000472	0.00604	CbGeAlD
Ketotifen—PDE4B—lymph node—breast cancer	0.000442	0.00565	CbGeAlD
Ketotifen—Azatadine—CYP3A4—breast cancer	0.000435	0.26	CrCbGaD
Ketotifen—HRH1—female reproductive system—breast cancer	0.000434	0.00555	CbGeAlD
Ketotifen—HRH1—adrenal gland—breast cancer	0.000424	0.00542	CbGeAlD
Ketotifen—Loratadine—CYP3A4—breast cancer	0.000413	0.247	CrCbGaD
Ketotifen—HRH1—female gonad—breast cancer	0.000395	0.00505	CbGeAlD
Ketotifen—HRH1—endocrine gland—breast cancer	0.000368	0.0047	CbGeAlD
Ketotifen—Loratadine—ABCB1—breast cancer	0.000344	0.205	CrCbGaD
Ketotifen—HRH1—lymph node—breast cancer	0.000254	0.00325	CbGeAlD
Ketotifen—Nausea—Chlorambucil—breast cancer	0.000192	0.00117	CcSEcCtD
Ketotifen—Hepatitis—Capecitabine—breast cancer	0.000191	0.00117	CcSEcCtD
Ketotifen—Thrombocytopenia—Fluorouracil—breast cancer	0.00019	0.00116	CcSEcCtD
Ketotifen—Dizziness—Tamoxifen—breast cancer	0.00019	0.00116	CcSEcCtD
Ketotifen—Increased appetite—Doxorubicin—breast cancer	0.00019	0.00116	CcSEcCtD
Ketotifen—Vomiting—Vinblastine—breast cancer	0.000188	0.00115	CcSEcCtD
Ketotifen—Diarrhoea—Goserelin—breast cancer	0.000188	0.00115	CcSEcCtD
Ketotifen—Erythema multiforme—Docetaxel—breast cancer	0.000187	0.00114	CcSEcCtD
Ketotifen—Urticaria—Thiotepa—breast cancer	0.000187	0.00114	CcSEcCtD
Ketotifen—Abdominal pain—Thiotepa—breast cancer	0.000186	0.00113	CcSEcCtD
Ketotifen—Body temperature increased—Thiotepa—breast cancer	0.000186	0.00113	CcSEcCtD
Ketotifen—Headache—Vinblastine—breast cancer	0.000186	0.00113	CcSEcCtD
Ketotifen—Insomnia—Irinotecan—breast cancer	0.000184	0.00112	CcSEcCtD
Ketotifen—Vomiting—Tamoxifen—breast cancer	0.000183	0.00112	CcSEcCtD
Ketotifen—Paraesthesia—Mitoxantrone—breast cancer	0.000182	0.00111	CcSEcCtD
Ketotifen—Paraesthesia—Irinotecan—breast cancer	0.000182	0.00111	CcSEcCtD
Ketotifen—Syncope—Paclitaxel—breast cancer	0.000182	0.00111	CcSEcCtD
Ketotifen—Dizziness—Goserelin—breast cancer	0.000182	0.00111	CcSEcCtD
Ketotifen—Rash—Tamoxifen—breast cancer	0.000181	0.00111	CcSEcCtD
Ketotifen—Dermatitis—Tamoxifen—breast cancer	0.000181	0.00111	CcSEcCtD
Ketotifen—Erythema multiforme—Capecitabine—breast cancer	0.000181	0.0011	CcSEcCtD
Ketotifen—Somnolence—Irinotecan—breast cancer	0.00018	0.0011	CcSEcCtD
Ketotifen—Somnolence—Mitoxantrone—breast cancer	0.00018	0.0011	CcSEcCtD
Ketotifen—Headache—Tamoxifen—breast cancer	0.00018	0.0011	CcSEcCtD
Ketotifen—Vomiting—Melphalan—breast cancer	0.000179	0.00109	CcSEcCtD
Ketotifen—Insomnia—Gemcitabine—breast cancer	0.000179	0.00109	CcSEcCtD
Ketotifen—Loss of consciousness—Paclitaxel—breast cancer	0.000178	0.00109	CcSEcCtD
Ketotifen—Rash—Melphalan—breast cancer	0.000178	0.00108	CcSEcCtD
Ketotifen—Paraesthesia—Gemcitabine—breast cancer	0.000178	0.00108	CcSEcCtD
Ketotifen—Dermatitis—Melphalan—breast cancer	0.000177	0.00108	CcSEcCtD
Ketotifen—Nausea—Vinblastine—breast cancer	0.000176	0.00107	CcSEcCtD
Ketotifen—Insomnia—Fluorouracil—breast cancer	0.000176	0.00107	CcSEcCtD
Ketotifen—Somnolence—Gemcitabine—breast cancer	0.000176	0.00107	CcSEcCtD
Ketotifen—Hypertension—Paclitaxel—breast cancer	0.000175	0.00107	CcSEcCtD
Ketotifen—Vomiting—Goserelin—breast cancer	0.000175	0.00107	CcSEcCtD
Ketotifen—Paraesthesia—Fluorouracil—breast cancer	0.000175	0.00106	CcSEcCtD
Ketotifen—Pruritus—Vinorelbine—breast cancer	0.000174	0.00106	CcSEcCtD
Ketotifen—Pain—Mitoxantrone—breast cancer	0.000174	0.00106	CcSEcCtD
Ketotifen—Pain—Irinotecan—breast cancer	0.000174	0.00106	CcSEcCtD
Ketotifen—Rash—Goserelin—breast cancer	0.000173	0.00106	CcSEcCtD
Ketotifen—Dermatitis—Goserelin—breast cancer	0.000173	0.00106	CcSEcCtD
Ketotifen—Somnolence—Fluorouracil—breast cancer	0.000173	0.00105	CcSEcCtD
Ketotifen—Headache—Goserelin—breast cancer	0.000172	0.00105	CcSEcCtD
Ketotifen—Nausea—Tamoxifen—breast cancer	0.000171	0.00104	CcSEcCtD
Ketotifen—Pain—Gemcitabine—breast cancer	0.000169	0.00103	CcSEcCtD
Ketotifen—Dry mouth—Paclitaxel—breast cancer	0.000169	0.00103	CcSEcCtD
Ketotifen—Diarrhoea—Vinorelbine—breast cancer	0.000168	0.00103	CcSEcCtD
Ketotifen—Nausea—Melphalan—breast cancer	0.000167	0.00102	CcSEcCtD
Ketotifen—Pruritus—Thiotepa—breast cancer	0.000166	0.00101	CcSEcCtD
Ketotifen—Pain—Fluorouracil—breast cancer	0.000166	0.00101	CcSEcCtD
Ketotifen—Gastrointestinal pain—Irinotecan—breast cancer	0.000166	0.00101	CcSEcCtD
Ketotifen—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000166	0.00101	CcSEcCtD
Ketotifen—Infection—Paclitaxel—breast cancer	0.000164	0.001	CcSEcCtD
Ketotifen—Nausea—Goserelin—breast cancer	0.000163	0.000996	CcSEcCtD
Ketotifen—Shock—Paclitaxel—breast cancer	0.000163	0.000993	CcSEcCtD
Ketotifen—Dizziness—Vinorelbine—breast cancer	0.000163	0.000993	CcSEcCtD
Ketotifen—Thrombocytopenia—Paclitaxel—breast cancer	0.000162	0.000989	CcSEcCtD
Ketotifen—Urticaria—Mitoxantrone—breast cancer	0.000161	0.000984	CcSEcCtD
Ketotifen—Diarrhoea—Thiotepa—breast cancer	0.000161	0.000981	CcSEcCtD
Ketotifen—Abdominal pain—Irinotecan—breast cancer	0.00016	0.000979	CcSEcCtD
Ketotifen—Body temperature increased—Mitoxantrone—breast cancer	0.00016	0.000979	CcSEcCtD
Ketotifen—Abdominal pain—Mitoxantrone—breast cancer	0.00016	0.000979	CcSEcCtD
Ketotifen—Body temperature increased—Irinotecan—breast cancer	0.00016	0.000979	CcSEcCtD
Ketotifen—Drowsiness—Methotrexate—breast cancer	0.000159	0.000967	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000157	0.000959	CcSEcCtD
Ketotifen—Vomiting—Vinorelbine—breast cancer	0.000156	0.000954	CcSEcCtD
Ketotifen—Body temperature increased—Gemcitabine—breast cancer	0.000156	0.000953	CcSEcCtD
Ketotifen—Dizziness—Thiotepa—breast cancer	0.000155	0.000948	CcSEcCtD
Ketotifen—Rash—Vinorelbine—breast cancer	0.000155	0.000947	CcSEcCtD
Ketotifen—Dermatitis—Vinorelbine—breast cancer	0.000155	0.000946	CcSEcCtD
Ketotifen—Urticaria—Fluorouracil—breast cancer	0.000154	0.000942	CcSEcCtD
Ketotifen—Headache—Vinorelbine—breast cancer	0.000154	0.00094	CcSEcCtD
Ketotifen—Syncope—Docetaxel—breast cancer	0.000154	0.00094	CcSEcCtD
Ketotifen—Body temperature increased—Fluorouracil—breast cancer	0.000154	0.000937	CcSEcCtD
Ketotifen—Weight increased—Epirubicin—breast cancer	0.000151	0.000924	CcSEcCtD
Ketotifen—Loss of consciousness—Docetaxel—breast cancer	0.000151	0.000922	CcSEcCtD
Ketotifen—Insomnia—Paclitaxel—breast cancer	0.00015	0.000913	CcSEcCtD
Ketotifen—Epistaxis—Methotrexate—breast cancer	0.00015	0.000912	CcSEcCtD
Ketotifen—Vomiting—Thiotepa—breast cancer	0.000149	0.000912	CcSEcCtD
Ketotifen—Syncope—Capecitabine—breast cancer	0.000149	0.000911	CcSEcCtD
Ketotifen—Paraesthesia—Paclitaxel—breast cancer	0.000149	0.000907	CcSEcCtD
Ketotifen—Hypertension—Docetaxel—breast cancer	0.000148	0.000905	CcSEcCtD
Ketotifen—Drowsiness—Epirubicin—breast cancer	0.000148	0.000905	CcSEcCtD
Ketotifen—Rash—Thiotepa—breast cancer	0.000148	0.000904	CcSEcCtD
Ketotifen—Dermatitis—Thiotepa—breast cancer	0.000148	0.000903	CcSEcCtD
Ketotifen—Headache—Thiotepa—breast cancer	0.000147	0.000898	CcSEcCtD
Ketotifen—Somnolence—Paclitaxel—breast cancer	0.000147	0.000898	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000147	0.000897	CcSEcCtD
Ketotifen—Loss of consciousness—Capecitabine—breast cancer	0.000146	0.000892	CcSEcCtD
Ketotifen—Nausea—Vinorelbine—breast cancer	0.000146	0.000892	CcSEcCtD
Ketotifen—Hypertension—Capecitabine—breast cancer	0.000144	0.000877	CcSEcCtD
Ketotifen—Dry mouth—Docetaxel—breast cancer	0.000143	0.000873	CcSEcCtD
Ketotifen—Hepatitis—Methotrexate—breast cancer	0.000142	0.000868	CcSEcCtD
Ketotifen—Pain—Paclitaxel—breast cancer	0.000142	0.000863	CcSEcCtD
Ketotifen—Weight increased—Doxorubicin—breast cancer	0.00014	0.000855	CcSEcCtD
Ketotifen—Epistaxis—Epirubicin—breast cancer	0.00014	0.000854	CcSEcCtD
Ketotifen—Pruritus—Gemcitabine—breast cancer	0.00014	0.000853	CcSEcCtD
Ketotifen—Nausea—Thiotepa—breast cancer	0.00014	0.000852	CcSEcCtD
Ketotifen—Infection—Docetaxel—breast cancer	0.000139	0.00085	CcSEcCtD
Ketotifen—Diarrhoea—Irinotecan—breast cancer	0.000139	0.000847	CcSEcCtD
Ketotifen—Diarrhoea—Mitoxantrone—breast cancer	0.000139	0.000847	CcSEcCtD
Ketotifen—Dry mouth—Capecitabine—breast cancer	0.000139	0.000845	CcSEcCtD
Ketotifen—Shock—Docetaxel—breast cancer	0.000138	0.000842	CcSEcCtD
Ketotifen—Pruritus—Fluorouracil—breast cancer	0.000138	0.000839	CcSEcCtD
Ketotifen—Thrombocytopenia—Docetaxel—breast cancer	0.000137	0.000838	CcSEcCtD
Ketotifen—Drowsiness—Doxorubicin—breast cancer	0.000137	0.000837	CcSEcCtD
Ketotifen—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000136	0.00083	CcSEcCtD
Ketotifen—Gastrointestinal pain—Paclitaxel—breast cancer	0.000135	0.000826	CcSEcCtD
Ketotifen—Diarrhoea—Gemcitabine—breast cancer	0.000135	0.000825	CcSEcCtD
Ketotifen—Infection—Capecitabine—breast cancer	0.000135	0.000823	CcSEcCtD
Ketotifen—Erythema multiforme—Methotrexate—breast cancer	0.000135	0.000821	CcSEcCtD
Ketotifen—Dizziness—Irinotecan—breast cancer	0.000134	0.000819	CcSEcCtD
Ketotifen—Shock—Capecitabine—breast cancer	0.000134	0.000815	CcSEcCtD
Ketotifen—Hepatitis—Epirubicin—breast cancer	0.000133	0.000813	CcSEcCtD
Ketotifen—Diarrhoea—Fluorouracil—breast cancer	0.000133	0.000811	CcSEcCtD
Ketotifen—Thrombocytopenia—Capecitabine—breast cancer	0.000133	0.000811	CcSEcCtD
Ketotifen—Urticaria—Paclitaxel—breast cancer	0.000132	0.000802	CcSEcCtD
Ketotifen—Body temperature increased—Paclitaxel—breast cancer	0.000131	0.000798	CcSEcCtD
Ketotifen—Abdominal pain—Paclitaxel—breast cancer	0.000131	0.000798	CcSEcCtD
Ketotifen—Epistaxis—Doxorubicin—breast cancer	0.00013	0.00079	CcSEcCtD
Ketotifen—Vomiting—Irinotecan—breast cancer	0.000129	0.000787	CcSEcCtD
Ketotifen—Vomiting—Mitoxantrone—breast cancer	0.000129	0.000787	CcSEcCtD
Ketotifen—Dizziness—Fluorouracil—breast cancer	0.000129	0.000784	CcSEcCtD
Ketotifen—Rash—Mitoxantrone—breast cancer	0.000128	0.000781	CcSEcCtD
Ketotifen—Rash—Irinotecan—breast cancer	0.000128	0.000781	CcSEcCtD
Ketotifen—Dermatitis—Irinotecan—breast cancer	0.000128	0.00078	CcSEcCtD
Ketotifen—Dermatitis—Mitoxantrone—breast cancer	0.000128	0.00078	CcSEcCtD
Ketotifen—Headache—Irinotecan—breast cancer	0.000127	0.000776	CcSEcCtD
Ketotifen—Headache—Mitoxantrone—breast cancer	0.000127	0.000776	CcSEcCtD
Ketotifen—Insomnia—Docetaxel—breast cancer	0.000127	0.000774	CcSEcCtD
Ketotifen—Paraesthesia—Docetaxel—breast cancer	0.000126	0.000769	CcSEcCtD
Ketotifen—Erythema multiforme—Epirubicin—breast cancer	0.000126	0.000768	CcSEcCtD
Ketotifen—Vomiting—Gemcitabine—breast cancer	0.000126	0.000767	CcSEcCtD
Ketotifen—Somnolence—Docetaxel—breast cancer	0.000125	0.000761	CcSEcCtD
Ketotifen—Rash—Gemcitabine—breast cancer	0.000125	0.00076	CcSEcCtD
Ketotifen—Dermatitis—Gemcitabine—breast cancer	0.000125	0.00076	CcSEcCtD
Ketotifen—Headache—Gemcitabine—breast cancer	0.000124	0.000756	CcSEcCtD
Ketotifen—Vomiting—Fluorouracil—breast cancer	0.000124	0.000754	CcSEcCtD
Ketotifen—Hepatitis—Doxorubicin—breast cancer	0.000123	0.000752	CcSEcCtD
Ketotifen—Insomnia—Capecitabine—breast cancer	0.000123	0.000749	CcSEcCtD
Ketotifen—Rash—Fluorouracil—breast cancer	0.000123	0.000748	CcSEcCtD
Ketotifen—Dermatitis—Fluorouracil—breast cancer	0.000122	0.000747	CcSEcCtD
Ketotifen—Paraesthesia—Capecitabine—breast cancer	0.000122	0.000744	CcSEcCtD
Ketotifen—Headache—Fluorouracil—breast cancer	0.000122	0.000743	CcSEcCtD
Ketotifen—Nausea—Irinotecan—breast cancer	0.000121	0.000735	CcSEcCtD
Ketotifen—Nausea—Mitoxantrone—breast cancer	0.000121	0.000735	CcSEcCtD
Ketotifen—Pain—Docetaxel—breast cancer	0.00012	0.000732	CcSEcCtD
Ketotifen—Nausea—Gemcitabine—breast cancer	0.000117	0.000716	CcSEcCtD
Ketotifen—Pruritus—Paclitaxel—breast cancer	0.000117	0.000714	CcSEcCtD
Ketotifen—Erythema multiforme—Doxorubicin—breast cancer	0.000117	0.000711	CcSEcCtD
Ketotifen—Pain—Capecitabine—breast cancer	0.000116	0.000709	CcSEcCtD
Ketotifen—Nausea—Fluorouracil—breast cancer	0.000115	0.000704	CcSEcCtD
Ketotifen—Gastrointestinal pain—Docetaxel—breast cancer	0.000115	0.0007	CcSEcCtD
Ketotifen—Tension—Epirubicin—breast cancer	0.000114	0.000694	CcSEcCtD
Ketotifen—Diarrhoea—Paclitaxel—breast cancer	0.000113	0.000691	CcSEcCtD
Ketotifen—Nervousness—Epirubicin—breast cancer	0.000113	0.000687	CcSEcCtD
Ketotifen—Gastrointestinal pain—Capecitabine—breast cancer	0.000111	0.000678	CcSEcCtD
Ketotifen—Abdominal pain—Docetaxel—breast cancer	0.000111	0.000677	CcSEcCtD
Ketotifen—Body temperature increased—Docetaxel—breast cancer	0.000111	0.000677	CcSEcCtD
Ketotifen—Dizziness—Paclitaxel—breast cancer	0.000109	0.000668	CcSEcCtD
Ketotifen—Urticaria—Capecitabine—breast cancer	0.000108	0.000658	CcSEcCtD
Ketotifen—Body temperature increased—Capecitabine—breast cancer	0.000107	0.000655	CcSEcCtD
Ketotifen—Abdominal pain—Capecitabine—breast cancer	0.000107	0.000655	CcSEcCtD
Ketotifen—Tension—Doxorubicin—breast cancer	0.000105	0.000642	CcSEcCtD
Ketotifen—Vomiting—Paclitaxel—breast cancer	0.000105	0.000642	CcSEcCtD
Ketotifen—Rash—Paclitaxel—breast cancer	0.000104	0.000637	CcSEcCtD
Ketotifen—Dermatitis—Paclitaxel—breast cancer	0.000104	0.000636	CcSEcCtD
Ketotifen—Nervousness—Doxorubicin—breast cancer	0.000104	0.000636	CcSEcCtD
Ketotifen—Syncope—Epirubicin—breast cancer	0.000104	0.000634	CcSEcCtD
Ketotifen—Headache—Paclitaxel—breast cancer	0.000104	0.000633	CcSEcCtD
Ketotifen—Loss of consciousness—Epirubicin—breast cancer	0.000102	0.000622	CcSEcCtD
Ketotifen—Infection—Methotrexate—breast cancer	0.0001	0.000613	CcSEcCtD
Ketotifen—Hypertension—Epirubicin—breast cancer	0.0001	0.000611	CcSEcCtD
Ketotifen—Pruritus—Docetaxel—breast cancer	9.93e-05	0.000606	CcSEcCtD
Ketotifen—Thrombocytopenia—Methotrexate—breast cancer	9.9e-05	0.000604	CcSEcCtD
Ketotifen—Nausea—Paclitaxel—breast cancer	9.83e-05	0.0006	CcSEcCtD
Ketotifen—Dry mouth—Epirubicin—breast cancer	9.66e-05	0.000589	CcSEcCtD
Ketotifen—Syncope—Doxorubicin—breast cancer	9.62e-05	0.000587	CcSEcCtD
Ketotifen—Pruritus—Capecitabine—breast cancer	9.61e-05	0.000586	CcSEcCtD
Ketotifen—Diarrhoea—Docetaxel—breast cancer	9.6e-05	0.000586	CcSEcCtD
Ketotifen—Loss of consciousness—Doxorubicin—breast cancer	9.43e-05	0.000575	CcSEcCtD
Ketotifen—Infection—Epirubicin—breast cancer	9.4e-05	0.000573	CcSEcCtD
Ketotifen—Shock—Epirubicin—breast cancer	9.31e-05	0.000568	CcSEcCtD
Ketotifen—Diarrhoea—Capecitabine—breast cancer	9.29e-05	0.000567	CcSEcCtD
Ketotifen—Dizziness—Docetaxel—breast cancer	9.28e-05	0.000566	CcSEcCtD
Ketotifen—Thrombocytopenia—Epirubicin—breast cancer	9.27e-05	0.000565	CcSEcCtD
Ketotifen—Hypertension—Doxorubicin—breast cancer	9.26e-05	0.000565	CcSEcCtD
Ketotifen—Insomnia—Methotrexate—breast cancer	9.15e-05	0.000558	CcSEcCtD
Ketotifen—Paraesthesia—Methotrexate—breast cancer	9.08e-05	0.000554	CcSEcCtD
Ketotifen—Somnolence—Methotrexate—breast cancer	8.99e-05	0.000548	CcSEcCtD
Ketotifen—Dizziness—Capecitabine—breast cancer	8.98e-05	0.000548	CcSEcCtD
Ketotifen—Dry mouth—Doxorubicin—breast cancer	8.93e-05	0.000545	CcSEcCtD
Ketotifen—Vomiting—Docetaxel—breast cancer	8.92e-05	0.000544	CcSEcCtD
Ketotifen—Rash—Docetaxel—breast cancer	8.85e-05	0.00054	CcSEcCtD
Ketotifen—Dermatitis—Docetaxel—breast cancer	8.84e-05	0.000539	CcSEcCtD
Ketotifen—Headache—Docetaxel—breast cancer	8.79e-05	0.000536	CcSEcCtD
Ketotifen—Infection—Doxorubicin—breast cancer	8.7e-05	0.000531	CcSEcCtD
Ketotifen—Pain—Methotrexate—breast cancer	8.65e-05	0.000527	CcSEcCtD
Ketotifen—Vomiting—Capecitabine—breast cancer	8.64e-05	0.000527	CcSEcCtD
Ketotifen—Shock—Doxorubicin—breast cancer	8.62e-05	0.000526	CcSEcCtD
Ketotifen—Thrombocytopenia—Doxorubicin—breast cancer	8.57e-05	0.000523	CcSEcCtD
Ketotifen—Rash—Capecitabine—breast cancer	8.57e-05	0.000522	CcSEcCtD
Ketotifen—Insomnia—Epirubicin—breast cancer	8.56e-05	0.000522	CcSEcCtD
Ketotifen—Dermatitis—Capecitabine—breast cancer	8.56e-05	0.000522	CcSEcCtD
Ketotifen—Headache—Capecitabine—breast cancer	8.51e-05	0.000519	CcSEcCtD
Ketotifen—Paraesthesia—Epirubicin—breast cancer	8.5e-05	0.000518	CcSEcCtD
Ketotifen—Somnolence—Epirubicin—breast cancer	8.41e-05	0.000513	CcSEcCtD
Ketotifen—Nausea—Docetaxel—breast cancer	8.33e-05	0.000508	CcSEcCtD
Ketotifen—Gastrointestinal pain—Methotrexate—breast cancer	8.27e-05	0.000504	CcSEcCtD
Ketotifen—Pain—Epirubicin—breast cancer	8.09e-05	0.000494	CcSEcCtD
Ketotifen—Nausea—Capecitabine—breast cancer	8.07e-05	0.000492	CcSEcCtD
Ketotifen—Urticaria—Methotrexate—breast cancer	8.03e-05	0.00049	CcSEcCtD
Ketotifen—Body temperature increased—Methotrexate—breast cancer	7.99e-05	0.000488	CcSEcCtD
Ketotifen—Abdominal pain—Methotrexate—breast cancer	7.99e-05	0.000488	CcSEcCtD
Ketotifen—Insomnia—Doxorubicin—breast cancer	7.92e-05	0.000483	CcSEcCtD
Ketotifen—Paraesthesia—Doxorubicin—breast cancer	7.86e-05	0.00048	CcSEcCtD
Ketotifen—Somnolence—Doxorubicin—breast cancer	7.78e-05	0.000475	CcSEcCtD
Ketotifen—Gastrointestinal pain—Epirubicin—breast cancer	7.74e-05	0.000472	CcSEcCtD
Ketotifen—Urticaria—Epirubicin—breast cancer	7.52e-05	0.000459	CcSEcCtD
Ketotifen—Pain—Doxorubicin—breast cancer	7.49e-05	0.000457	CcSEcCtD
Ketotifen—Abdominal pain—Epirubicin—breast cancer	7.48e-05	0.000456	CcSEcCtD
Ketotifen—Body temperature increased—Epirubicin—breast cancer	7.48e-05	0.000456	CcSEcCtD
Ketotifen—Gastrointestinal pain—Doxorubicin—breast cancer	7.16e-05	0.000437	CcSEcCtD
Ketotifen—Pruritus—Methotrexate—breast cancer	7.15e-05	0.000436	CcSEcCtD
Ketotifen—Urticaria—Doxorubicin—breast cancer	6.96e-05	0.000424	CcSEcCtD
Ketotifen—Abdominal pain—Doxorubicin—breast cancer	6.92e-05	0.000422	CcSEcCtD
Ketotifen—Body temperature increased—Doxorubicin—breast cancer	6.92e-05	0.000422	CcSEcCtD
Ketotifen—Diarrhoea—Methotrexate—breast cancer	6.92e-05	0.000422	CcSEcCtD
Ketotifen—Pruritus—Epirubicin—breast cancer	6.7e-05	0.000408	CcSEcCtD
Ketotifen—Dizziness—Methotrexate—breast cancer	6.69e-05	0.000408	CcSEcCtD
Ketotifen—Diarrhoea—Epirubicin—breast cancer	6.48e-05	0.000395	CcSEcCtD
Ketotifen—Vomiting—Methotrexate—breast cancer	6.43e-05	0.000392	CcSEcCtD
Ketotifen—Rash—Methotrexate—breast cancer	6.38e-05	0.000389	CcSEcCtD
Ketotifen—Dermatitis—Methotrexate—breast cancer	6.37e-05	0.000389	CcSEcCtD
Ketotifen—Headache—Methotrexate—breast cancer	6.34e-05	0.000386	CcSEcCtD
Ketotifen—Dizziness—Epirubicin—breast cancer	6.26e-05	0.000382	CcSEcCtD
Ketotifen—Pruritus—Doxorubicin—breast cancer	6.2e-05	0.000378	CcSEcCtD
Ketotifen—Vomiting—Epirubicin—breast cancer	6.02e-05	0.000367	CcSEcCtD
Ketotifen—Nausea—Methotrexate—breast cancer	6.01e-05	0.000366	CcSEcCtD
Ketotifen—Diarrhoea—Doxorubicin—breast cancer	5.99e-05	0.000365	CcSEcCtD
Ketotifen—Rash—Epirubicin—breast cancer	5.97e-05	0.000364	CcSEcCtD
Ketotifen—Dermatitis—Epirubicin—breast cancer	5.96e-05	0.000364	CcSEcCtD
Ketotifen—Headache—Epirubicin—breast cancer	5.93e-05	0.000362	CcSEcCtD
Ketotifen—Dizziness—Doxorubicin—breast cancer	5.79e-05	0.000353	CcSEcCtD
Ketotifen—Nausea—Epirubicin—breast cancer	5.62e-05	0.000343	CcSEcCtD
Ketotifen—Vomiting—Doxorubicin—breast cancer	5.57e-05	0.00034	CcSEcCtD
Ketotifen—Rash—Doxorubicin—breast cancer	5.52e-05	0.000337	CcSEcCtD
Ketotifen—Dermatitis—Doxorubicin—breast cancer	5.52e-05	0.000336	CcSEcCtD
Ketotifen—Headache—Doxorubicin—breast cancer	5.49e-05	0.000335	CcSEcCtD
Ketotifen—Nausea—Doxorubicin—breast cancer	5.2e-05	0.000317	CcSEcCtD
Ketotifen—PDE4D—Signaling Pathways—RAF1—breast cancer	8.22e-06	5.85e-05	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—IL6—breast cancer	8.21e-06	5.85e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTHLH—breast cancer	8.21e-06	5.85e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—BMP2—breast cancer	8.21e-06	5.85e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—RELA—breast cancer	8.18e-06	5.83e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CTNNB1—breast cancer	8.17e-06	5.82e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—ERBB2—breast cancer	8.13e-06	5.79e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CD—breast cancer	8.11e-06	5.77e-05	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—PIK3CA—breast cancer	8.03e-06	5.72e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MTOR—breast cancer	8.02e-06	5.71e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CB—breast cancer	8.02e-06	5.71e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SERPINE1—breast cancer	8.02e-06	5.71e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MMP9—breast cancer	8.01e-06	5.71e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—CDKN1A—breast cancer	7.98e-06	5.69e-05	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—HRAS—breast cancer	7.98e-06	5.68e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PTEN—breast cancer	7.96e-06	5.67e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EDNRB—breast cancer	7.95e-06	5.66e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—KRAS—breast cancer	7.94e-06	5.65e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—PIK3CA—breast cancer	7.88e-06	5.61e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PGR—breast cancer	7.87e-06	5.61e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MDM2—breast cancer	7.85e-06	5.59e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—THBS1—breast cancer	7.83e-06	5.58e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—RAF1—breast cancer	7.82e-06	5.57e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MAPK8—breast cancer	7.79e-06	5.55e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—RELA—breast cancer	7.79e-06	5.55e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling by GPCR—AKT1—breast cancer	7.77e-06	5.53e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—ERBB2—breast cancer	7.74e-06	5.51e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CXCL8—breast cancer	7.71e-06	5.49e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—HRAS—breast cancer	7.66e-06	5.46e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—NOS3—breast cancer	7.66e-06	5.45e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CB—breast cancer	7.64e-06	5.44e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MTOR—breast cancer	7.64e-06	5.44e-05	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—IL6—breast cancer	7.63e-06	5.44e-05	CbGpPWpGaD
Ketotifen—PDE7B—Signaling Pathways—AKT1—breast cancer	7.58e-06	5.4e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CDKN1B—breast cancer	7.53e-06	5.36e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FLT1—breast cancer	7.48e-06	5.33e-05	CbGpPWpGaD
Ketotifen—PDE4D—GPCR downstream signaling—AKT1—breast cancer	7.45e-06	5.31e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SQSTM1—breast cancer	7.44e-06	5.3e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGF3—breast cancer	7.44e-06	5.3e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CG—breast cancer	7.41e-06	5.28e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—SRC—breast cancer	7.39e-06	5.26e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CASP3—breast cancer	7.38e-06	5.26e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL2—breast cancer	7.37e-06	5.25e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—JAG1—breast cancer	7.35e-06	5.23e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CXCL8—breast cancer	7.34e-06	5.23e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—IL6—breast cancer	7.33e-06	5.22e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NOTCH3—breast cancer	7.32e-06	5.21e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PARP1—breast cancer	7.32e-06	5.21e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—PIK3CA—breast cancer	7.29e-06	5.19e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—HRAS—breast cancer	7.29e-06	5.19e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MDM2—breast cancer	7.26e-06	5.17e-05	CbGpPWpGaD
Ketotifen—PGD—Metabolism—AKT1—breast cancer	7.24e-06	5.16e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—RAF1—breast cancer	7.24e-06	5.16e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CALCA—breast cancer	7.23e-06	5.15e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—RELA—breast cancer	7.21e-06	5.13e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—VEGFA—breast cancer	7.19e-06	5.12e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CCND1—breast cancer	7.18e-06	5.12e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—JUN—breast cancer	7.17e-06	5.11e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CDKN1B—breast cancer	7.17e-06	5.1e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—ERBB2—breast cancer	7.16e-06	5.1e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—RPS6—breast cancer	7.14e-06	5.09e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—STAT3—breast cancer	7.12e-06	5.07e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CTNNB1—breast cancer	7.11e-06	5.07e-05	CbGpPWpGaD
Ketotifen—PDE4A—GPCR downstream signaling—AKT1—breast cancer	7.09e-06	5.05e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGF4—breast cancer	7.09e-06	5.05e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CB—breast cancer	7.07e-06	5.03e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MTOR—breast cancer	7.07e-06	5.03e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CXCL12—breast cancer	7.06e-06	5.03e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CXCR4—breast cancer	7.06e-06	5.03e-05	CbGpPWpGaD
Ketotifen—PDE7A—Signaling Pathways—AKT1—breast cancer	7.04e-06	5.02e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CASP3—breast cancer	7.02e-06	5e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL2—breast cancer	7.01e-06	5e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—IL6—breast cancer	6.98e-06	4.97e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MMP9—breast cancer	6.97e-06	4.97e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—CDKN1A—breast cancer	6.95e-06	4.95e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PTEN—breast cancer	6.93e-06	4.94e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PAK1—breast cancer	6.93e-06	4.94e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CCND1—breast cancer	6.84e-06	4.87e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—JUN—breast cancer	6.82e-06	4.86e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TCF7L2—breast cancer	6.81e-06	4.85e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MAPK3—breast cancer	6.81e-06	4.85e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CXCL8—breast cancer	6.79e-06	4.84e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MAPK8—breast cancer	6.78e-06	4.83e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—AKT2—breast cancer	6.78e-06	4.83e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CTNNB1—breast cancer	6.77e-06	4.82e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling by GPCR—AKT1—breast cancer	6.76e-06	4.82e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—HRAS—breast cancer	6.75e-06	4.81e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CG—breast cancer	6.73e-06	4.79e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MMP9—breast cancer	6.64e-06	4.73e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CDKN1B—breast cancer	6.63e-06	4.72e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—MYC—breast cancer	6.62e-06	4.71e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—CDKN1A—breast cancer	6.61e-06	4.71e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TGFB1—breast cancer	6.6e-06	4.7e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PTEN—breast cancer	6.6e-06	4.7e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NOTCH2—breast cancer	6.56e-06	4.68e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HSP90AA1—breast cancer	6.56e-06	4.68e-05	CbGpPWpGaD
Ketotifen—PDE4B—GPCR downstream signaling—AKT1—breast cancer	6.56e-06	4.67e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CD—breast cancer	6.51e-06	4.64e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CASP3—breast cancer	6.5e-06	4.63e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL2—breast cancer	6.49e-06	4.62e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—EGFR—breast cancer	6.47e-06	4.61e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—IL6—breast cancer	6.46e-06	4.6e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MAPK8—breast cancer	6.46e-06	4.6e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling by GPCR—AKT1—breast cancer	6.44e-06	4.59e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—SRC—breast cancer	6.43e-06	4.58e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AGTR1—breast cancer	6.39e-06	4.55e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PRL—breast cancer	6.39e-06	4.55e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CCND1—breast cancer	6.33e-06	4.51e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—JUN—breast cancer	6.31e-06	4.5e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ADAM10—breast cancer	6.29e-06	4.48e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—STK11—breast cancer	6.29e-06	4.48e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CTNNB1—breast cancer	6.27e-06	4.46e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—VEGFA—breast cancer	6.26e-06	4.46e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PLG—breast cancer	6.22e-06	4.43e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—STAT3—breast cancer	6.2e-06	4.42e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—AKT2—breast cancer	6.15e-06	4.38e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MMP9—breast cancer	6.14e-06	4.37e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGF10—breast cancer	6.12e-06	4.36e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—CDKN1A—breast cancer	6.12e-06	4.36e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—SRC—breast cancer	6.12e-06	4.36e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—KRAS—breast cancer	6.12e-06	4.36e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PTEN—breast cancer	6.11e-06	4.35e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MAPK8—breast cancer	5.97e-06	4.25e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—VEGFA—breast cancer	5.96e-06	4.25e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling by GPCR—AKT1—breast cancer	5.96e-06	4.24e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MAPK3—breast cancer	5.92e-06	4.22e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CD—breast cancer	5.91e-06	4.21e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PDGFA—breast cancer	5.91e-06	4.21e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—STAT3—breast cancer	5.9e-06	4.2e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TGFBR2—breast cancer	5.82e-06	4.15e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—MYC—breast cancer	5.76e-06	4.1e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TGFB1—breast cancer	5.75e-06	4.09e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ITPR1—breast cancer	5.73e-06	4.08e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ERBB4—breast cancer	5.69e-06	4.05e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MMP3—breast cancer	5.69e-06	4.05e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—STAT5A—breast cancer	5.69e-06	4.05e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CB—breast cancer	5.68e-06	4.04e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—SRC—breast cancer	5.66e-06	4.03e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MAPK3—breast cancer	5.64e-06	4.02e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—EGFR—breast cancer	5.64e-06	4.01e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—PIK3CA—breast cancer	5.62e-06	4e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—VEGFA—breast cancer	5.52e-06	3.93e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SMAD4—breast cancer	5.51e-06	3.93e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—MYC—breast cancer	5.48e-06	3.91e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IGF1R—breast cancer	5.48e-06	3.9e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TGFB1—breast cancer	5.47e-06	3.9e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—STAT3—breast cancer	5.46e-06	3.89e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—CXCL8—breast cancer	5.45e-06	3.88e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—TP53—breast cancer	5.44e-06	3.87e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HES1—breast cancer	5.38e-06	3.83e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—EGFR—breast cancer	5.36e-06	3.82e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NCOR1—breast cancer	5.35e-06	3.81e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PLA2G4A—breast cancer	5.35e-06	3.81e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—KRAS—breast cancer	5.32e-06	3.79e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CSF2—breast cancer	5.29e-06	3.77e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGF1—breast cancer	5.29e-06	3.77e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—RAF1—breast cancer	5.28e-06	3.76e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NRG1—breast cancer	5.25e-06	3.74e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MAPK3—breast cancer	5.22e-06	3.72e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—H2AFX—breast cancer	5.22e-06	3.71e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—IL2—breast cancer	5.21e-06	3.71e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—HRAS—breast cancer	5.2e-06	3.7e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—E2F1—breast cancer	5.18e-06	3.69e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CB—breast cancer	5.15e-06	3.67e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—MYC—breast cancer	5.07e-06	3.61e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—KRAS—breast cancer	5.07e-06	3.61e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TGFB1—breast cancer	5.06e-06	3.61e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—IL6—breast cancer	4.98e-06	3.54e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SPP1—breast cancer	4.98e-06	3.54e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—EGFR—breast cancer	4.96e-06	3.54e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—CXCL8—breast cancer	4.95e-06	3.53e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ERBB3—breast cancer	4.92e-06	3.5e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGFR2—breast cancer	4.91e-06	3.5e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—PIK3CA—breast cancer	4.89e-06	3.48e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL2—breast cancer	4.73e-06	3.37e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—TP53—breast cancer	4.73e-06	3.37e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TERT—breast cancer	4.72e-06	3.36e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—KRAS—breast cancer	4.69e-06	3.34e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—PIK3CA—breast cancer	4.66e-06	3.32e-05	CbGpPWpGaD
Ketotifen—PDE4C—Signaling Pathways—AKT1—breast cancer	4.59e-06	3.27e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FGFR1—breast cancer	4.58e-06	3.26e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—HRAS—breast cancer	4.53e-06	3.22e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HIF1A—breast cancer	4.51e-06	3.21e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—TP53—breast cancer	4.5e-06	3.21e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—LEP—breast cancer	4.4e-06	3.14e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CAV1—breast cancer	4.36e-06	3.11e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—IL6—breast cancer	4.33e-06	3.08e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KDR—breast cancer	4.31e-06	3.07e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—PIK3CA—breast cancer	4.31e-06	3.07e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—HRAS—breast cancer	4.31e-06	3.07e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ESR1—breast cancer	4.2e-06	2.99e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—TP53—breast cancer	4.17e-06	2.97e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—FN1—breast cancer	4.15e-06	2.96e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—IL6—breast cancer	4.12e-06	2.94e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NFKBIA—breast cancer	4.1e-06	2.92e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NOTCH1—breast cancer	4.06e-06	2.89e-05	CbGpPWpGaD
Ketotifen—PDE4D—Signaling Pathways—AKT1—breast cancer	4e-06	2.85e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—HRAS—breast cancer	3.99e-06	2.84e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KIT—breast cancer	3.97e-06	2.83e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—APC—breast cancer	3.97e-06	2.83e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CG—breast cancer	3.97e-06	2.83e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EGF—breast cancer	3.93e-06	2.8e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—IL6—breast cancer	3.81e-06	2.72e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—MAPK3—breast cancer	3.81e-06	2.71e-05	CbGpPWpGaD
Ketotifen—PDE4A—Signaling Pathways—AKT1—breast cancer	3.8e-06	2.71e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—BRAF—breast cancer	3.74e-06	2.66e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IGF1—breast cancer	3.64e-06	2.59e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKT2—breast cancer	3.64e-06	2.59e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—EGFR—breast cancer	3.62e-06	2.58e-05	CbGpPWpGaD
Ketotifen—PDE4B—Signaling Pathways—AKT1—breast cancer	3.52e-06	2.51e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CD—breast cancer	3.49e-06	2.49e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—PIK3CA—breast cancer	3.46e-06	2.46e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SERPINE1—breast cancer	3.46e-06	2.46e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—KRAS—breast cancer	3.42e-06	2.44e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—NOS3—breast cancer	3.3e-06	2.35e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—PIK3CA—breast cancer	3.14e-06	2.24e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MDM2—breast cancer	3.13e-06	2.23e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—RAF1—breast cancer	3.12e-06	2.22e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—RELA—breast cancer	3.11e-06	2.21e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—ERBB2—breast cancer	3.09e-06	2.2e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MTOR—breast cancer	3.04e-06	2.17e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CB—breast cancer	3.04e-06	2.17e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CXCL8—breast cancer	2.93e-06	2.08e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—HRAS—breast cancer	2.91e-06	2.07e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CDKN1B—breast cancer	2.86e-06	2.04e-05	CbGpPWpGaD
Ketotifen—HRH1—GPCR downstream signaling—AKT1—breast cancer	2.83e-06	2.01e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CASP3—breast cancer	2.8e-06	1.99e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL2—breast cancer	2.8e-06	1.99e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—IL6—breast cancer	2.78e-06	1.98e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CCND1—breast cancer	2.73e-06	1.94e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—JUN—breast cancer	2.72e-06	1.94e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CTNNB1—breast cancer	2.7e-06	1.92e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MMP9—breast cancer	2.65e-06	1.88e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—CDKN1A—breast cancer	2.64e-06	1.88e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PTEN—breast cancer	2.63e-06	1.87e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MAPK8—breast cancer	2.57e-06	1.83e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling by GPCR—AKT1—breast cancer	2.57e-06	1.83e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—SRC—breast cancer	2.44e-06	1.74e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—VEGFA—breast cancer	2.38e-06	1.69e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—STAT3—breast cancer	2.35e-06	1.68e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MAPK3—breast cancer	2.25e-06	1.6e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—MYC—breast cancer	2.19e-06	1.56e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TGFB1—breast cancer	2.18e-06	1.55e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—EGFR—breast cancer	2.14e-06	1.52e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—KRAS—breast cancer	2.02e-06	1.44e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—PIK3CA—breast cancer	1.86e-06	1.32e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—TP53—breast cancer	1.8e-06	1.28e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—HRAS—breast cancer	1.72e-06	1.22e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—IL6—breast cancer	1.64e-06	1.17e-05	CbGpPWpGaD
Ketotifen—HRH1—Signaling Pathways—AKT1—breast cancer	1.52e-06	1.08e-05	CbGpPWpGaD
